As we advance, the dynamic landscape of gastric cancer treatment demands continued investigation into FGFR2’s molecular mechanisms and therapeutic potential, promising a future where more personalized and effective treatment options are available for patients battling this malignancy. The gene discussed is FGFR2; the disease is gastric cancer.